BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

839 related articles for article (PubMed ID: 29486047)

  • 1. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases.
    Cui L; Lu H; Lee YH
    Mass Spectrom Rev; 2018 Nov; 37(6):772-792. PubMed ID: 29486047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges, progress and promises of metabolite annotation for LC-MS-based metabolomics.
    Chaleckis R; Meister I; Zhang P; Wheelock CE
    Curr Opin Biotechnol; 2019 Feb; 55():44-50. PubMed ID: 30138778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An untargeted metabolomics-driven approach based on LC-TOF/MS and LC-MS/MS for the screening of xenobiotics and metabolites of Zhi-Zi-Da-Huang decoction in rat plasma.
    Wu H; Li X; Yan X; An L; Luo K; Shao M; Jiang Y; Xie R; Feng F
    J Pharm Biomed Anal; 2015 Nov; 115():315-22. PubMed ID: 26275719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced MS/MS coverage for metabolite identification in LC-MS-based untargeted metabolomics by target-directed data dependent acquisition with time-staggered precursor ion list.
    Wang Y; Feng R; Wang R; Yang F; Li P; Wan JB
    Anal Chim Acta; 2017 Nov; 992():67-75. PubMed ID: 29054151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput metabolomics screen coupled with multivariate statistical analysis identifies therapeutic targets in alcoholic liver disease rats using liquid chromatography-mass spectrometry.
    Fang H; Zhang AH; Sun H; Yu JB; Wang L; Wang XJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1109():112-120. PubMed ID: 30743140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS Untargeted Analysis.
    Want EJ
    Methods Mol Biol; 2018; 1738():99-116. PubMed ID: 29654585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting human urinary metabolome by LC-MS/MS: a review.
    Rodríguez-Morató J; Pozo ÓJ; Marcos J
    Bioanalysis; 2018 Apr; 10(7):489-516. PubMed ID: 29561651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Solid-Phase Microextraction-Liquid Chromatography-Mass Spectrometry for Microbial Untargeted Metabolomics.
    Mousavi F; Bojko B; Pawliszyn J
    Methods Mol Biol; 2019; 1859():133-152. PubMed ID: 30421227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untargeted Metabolomics Strategies-Challenges and Emerging Directions.
    Schrimpe-Rutledge AC; Codreanu SG; Sherrod SD; McLean JA
    J Am Soc Mass Spectrom; 2016 Dec; 27(12):1897-1905. PubMed ID: 27624161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Data-Independent Targeted Metabolomics Method for Relative Quantification Using Liquid Chromatography Coupled with Tandem Mass Spectrometry.
    Chen Y; Zhou Z; Yang W; Bi N; Xu J; He J; Zhang R; Wang L; Abliz Z
    Anal Chem; 2017 Jul; 89(13):6954-6962. PubMed ID: 28574715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of peak-picking workflows for untargeted liquid chromatography/high-resolution mass spectrometry metabolomics data analysis.
    Rafiei A; Sleno L
    Rapid Commun Mass Spectrom; 2015 Jan; 29(1):119-27. PubMed ID: 25462372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isotope Labeling-Assisted Evaluation of Hydrophilic and Hydrophobic Liquid Chromatograph-Mass Spectrometry for Metabolomics Profiling.
    Xie B; Wang Y; Jones DR; Dey KK; Wang X; Li Y; Cho JH; Shaw TI; Tan H; Peng J
    Anal Chem; 2018 Jul; 90(14):8538-8545. PubMed ID: 29883117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic reaction network-based recursive metabolite annotation for untargeted metabolomics.
    Shen X; Wang R; Xiong X; Yin Y; Cai Y; Ma Z; Liu N; Zhu ZJ
    Nat Commun; 2019 Apr; 10(1):1516. PubMed ID: 30944337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing untargeted metabolomics using data-independent acquisition mass spectrometry technology.
    Wang R; Yin Y; Zhu ZJ
    Anal Bioanal Chem; 2019 Jul; 411(19):4349-4357. PubMed ID: 30847570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in metabolite identification.
    Wishart DS
    Bioanalysis; 2011 Aug; 3(15):1769-82. PubMed ID: 21827274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of altered urinary metabolomic profiles of invasive ductal carcinoma of breast using targeted and untargeted approaches.
    More TH; Taware R; Taunk K; Chanukuppa V; Naik V; Mane A; Rapole S
    Metabolomics; 2018 Aug; 14(8):107. PubMed ID: 30830381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization study for metabolomics analysis of human sweat by liquid chromatography-tandem mass spectrometry in high resolution mode.
    Calderón-Santiago M; Priego-Capote F; Jurado-Gámez B; Luque de Castro MD
    J Chromatogr A; 2014 Mar; 1333():70-8. PubMed ID: 24529403
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 42.